Sherri Z Millis

Years Active: 2021-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Mrinal M Gounder, Narasimhan P Agaram, Sally E Trabucco, Victoria Robinson, Richard A Ferraro, Sherri Z Millis, Anita Krishnan, Jessica Lee, Steven Attia, Wassim Abida, Alexander E Drilon, Ping Chi, Sandra P D' Angelo, Mark A Dickson, Mary Lou Keohan, Ciara M Kelly, Mark Agulnik, Sant P Chawla, Edwin Choy, Rashmi Chugh, Christian F Meyer, Parvathi A Myer, Jessica L Moore, Ross A Okimoto, Raphael Etomar Pollock, Vinod Ravi, Arun S Singh, Neeta Somaiah, Andrew J Wagner, John H Healey, Garrett M Frampton, Jeffrey M Venstrom, Jeffery S Ross, Marc Ladanyi, Samuel Singer, Murray F Brennan, Gary K Schwartz, Alexander J F Lazar, David M Thomas, Robert G Maki, William D Tap, Siraj M Ali, Dexter X Jin
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma. Nature communications 13 (1) (2022)
Nathan D Seligson, Joy Tang, Dexter X Jin, Monica P Bennett, Julia A Elvin, Kiley Graim, John L Hays, Sherri Z Millis, Wayne O Miles, James L Chen
Drivers of genomic loss of heterozygosity in leiomyosarcoma are distinct from carcinomas. NPJ precision oncology 6 (1) (2022)
Nathan D Seligson, Richard D Maradiaga, Colin M Stets, Howard M Katzenstein, Sherri Z Millis, Alan Rogers, John L Hays, James L Chen
Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target. NPJ precision oncology 5 (1) (2021)

Sherri Z Millis.css-eqlu8i{font-size:small;padding-left:4px;}